Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Christoph Driessen, MD, Jürgen Bader, Marianne Kraus

Blood (2010) 116 (21): 4069.

https://doi.org/10.1182/blood.V116.21.4069.4069

Published: 2010

Journal Articles

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Terry H. Landowski, PhD, Aluvia M Escalante, Andrew Jefferson, Robert T Dorr, Ronald Lynch

Blood (2008) 112 (11): 3677.

https://doi.org/10.1182/blood.V112.11.3677.3677

Published: 2008

Journal Articles

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

Huanyu Dou, Christopher J. Destache, Justin R. Morehead, R. Lee Mosley, Michael D. Boska, Jeffrey Kingsley, Santhi Gorantla, Larisa Poluektova, Jay A. Nelson, Mahesh Chaubal, Jane Werling, James Kipp, Barrett E. Rabinow, Howard E. Gendelman

Blood (2006) 108 (8): 2827–2835.

https://doi.org/10.1182/blood-2006-03-012534

Published: 2006

Includes: Multimedia, Supplemental data

Journal Articles

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals

Surendra Chavan, Sangeetha Kodoth, Rajendra Pahwa, Savita Pahwa

Blood (2001) 98 (2): 383–389.

https://doi.org/10.1182/blood.V98.2.383

Published: 2001

Journal Articles

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

Takayuki Ikezoe, Eric S. Daar, Jun-ichi Hisatake, Hirokuni Taguchi, H. Phillip Koeffler

Blood (2000) 96 (10): 3553–3559.

https://doi.org/10.1182/blood.V96.10.3553

Published: 2000

Journal Articles

HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression–independent mechanism

Wei Lu, Jean-Marie Andrieu

Blood (2000) 96 (1): 250–258.

https://doi.org/10.1182/blood.V96.1.250

Published: 2000

NARROW

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression–independent mechanism

Email alerts

ASH Publications

American Society of Hematology

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression–independent mechanism

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only